Welcome to our dedicated page for Phibro Animal news (Ticker: PAHC), a resource for investors and traders seeking the latest updates and insights on Phibro Animal stock.
Phibro Animal Health Corporation (PAHC) delivers essential animal health solutions and mineral nutrition products for global food production systems. This news hub provides investors and industry professionals with timely updates on corporate developments, financial performance, and operational milestones.
Access official press releases and curated analysis covering PAHC's strategic initiatives across its three core segments: Animal Health pharmaceuticals, Mineral Nutrition supplements, and Performance Products. Track updates including earnings reports, product innovations, regulatory developments, and partnership announcements that impact the livestock health sector.
This centralized resource enables stakeholders to monitor PAHC's responses to industry challenges and opportunities, from disease prevention advancements to nutritional science breakthroughs. Content is organized for efficient scanning while maintaining technical accuracy for veterinary professionals and investors alike.
Bookmark this page for direct access to PAHC's latest corporate communications and market-moving updates. Combine regular monitoring with historical context to inform your analysis of this animal health sector leader.
Phibro Animal Health reported strong financial results for the third quarter, with net sales increasing by 7% and adjusted EBITDA up by 9%. The company affirmed its fiscal year 2024 guidance, including net sales of $980 million to $1.020 billion and adjusted diluted EPS of $1.04 to $1.16. Phibro also updated its guidance for net income and diluted EPS due to recent developments.
Phibro Animal Health (PAHC) announced a quarterly cash dividend of $0.12 per share on its Class A and Class B common stock, payable on June 26, 2024. The dividend will be distributed to stockholders of record as of June 5, 2024.
FAQ
What is the current stock price of Phibro Animal (PAHC)?
What is the market cap of Phibro Animal (PAHC)?
